Table 7.
STS Preoperative Adjusted Multivariate Associations With In‐Hospital Mortality
| Preoperative Biomarker Category | Odds Ratio (95% CI) | P Value |
|---|---|---|
| Galectin‐3 | ||
| Median 1 | 1 [REF] | |
| Median 2 | 1.18 (0.55–2.54) | 0.675 |
| Tercile 1 | 1 [REF] | |
| Tercile 2 | 1.06 (0.39–2.91) | 0.909 |
| Tercile 3 | 1.18 (0.47–2.94) | 0.728 |
| NT‐ProBNP | ||
| Median 1 | 1 [REF] | |
| Median 2 | 2.36 (0.81–6.87) | 0.117 |
| Tercile 1 | 1 [REF] | |
| Tercile 2 | 2.23 (0.45–11.12) | 0.328 |
| Tercile 3 | 4.37 (0.93–20.49) | 0.061 |
| ST‐2 | ||
| Median 1 | 1 [REF] | |
| Median 2 | 3.62 (1.43–9.15) | 0.007 |
| Tercile 1 | 1 [REF] | |
| Tercile 2 | 1.96 (0.59–6.45) | 0.269 |
| Tercile 3 | 2.96 (1.04–8.41) | 0.042 |
CI indicates confidence interval; NT‐ProBNP, N terminal Pro b‐type natriuretic peptide.
*Model corrects for age, sex, body surface area, atrial fibrillation, last preoperative serum creatinine, presence of diabetes mellitus, ejection fraction <40%, hypertension, preoperative intra‐aortic balloon pump use, prior myocardial infarction, presence of any vascular disease, unstable angina, renal failure, chronic obstructive pulmonary disease, left main stenosis >50%, prior coronary artery bypass graft, prior percutaneous coronary intervention, date of operation, and urgent and emergent priority.